MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

EndoChoice Holdings Company Profile (NYSE:GI)

Consensus Ratings for EndoChoice Holdings (NYSE:GI) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $15.33 (218.12% upside)

Analysts' Ratings History for EndoChoice Holdings (NYSE:GI)
Show:
DateFirmActionRatingPrice TargetActions
3/24/2016Bank of AmericaDowngradeNeutral -> Underperform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2016Stifel NicolausLower Price TargetBuy$16.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2015JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015William BlairInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for EndoChoice Holdings (NYSE:GI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/4/2016Q116($0.55)($0.68)$18.34 million$18.46 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2016Q415($0.58)($0.53)$19.05 million$18.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.54)($0.47)$18.42 million$18.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.85)($0.60)$17.59 million$18.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for EndoChoice Holdings (NYSE:GI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.56)($0.56)($0.56)
Q2 20161($0.45)($0.45)($0.45)
Q3 20161($0.43)($0.43)($0.43)
Q4 20161($0.44)($0.44)($0.44)
Q1 20171($0.47)($0.47)($0.47)
Q2 20171($0.37)($0.37)($0.37)
Q3 20171($0.35)($0.35)($0.35)
Q4 20171($0.22)($0.22)($0.22)
(Data provided by Zacks Investment Research)
Dividend History for EndoChoice Holdings (NYSE:GI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for EndoChoice Holdings (NYSE:GI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/16/2016Mark GilreathCEOBuy20,000$5.06$101,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Mark GilreathCEOBuy5,018$5.02$25,190.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016David L KaufmanDirectorBuy89,450$4.81$430,254.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016David N GillCFOBuy2,000$4.70$9,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016William R EnquistDirectorBuy10,000$4.74$47,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016J Scott CarterDirectorBuy21,600$4.72$101,952.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016David N GillCFOBuy5,000$4.77$23,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for EndoChoice Holdings (NYSE:GI)
DateHeadline
06/23/16 03:23 PMEndoChoice Holdings Inc Just Recorded A Sigfniciant Increase - Engelwood Daily
06/23/16 07:06 AMEndoChoice Holdings, Inc. (NYSE:GI) Stock Momentum at Critical Inflection Point - CML News
06/21/16 08:49 AMEndoChoice Holdings, Inc. (NYSE:GI) Updated Price Targets - FTSE News
06/19/16 03:54 PMEndoChoice Holdings, Inc. (NYSE:GI) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 04:43 AMRecently Issued Stock Ratings For EndoChoice Holdings, Inc. (NYSE:GI) - Fiscal Standard
06/10/16 04:20 PMEndoChoice Holdings, Inc. (NYSE:GI) Current Analyst Ratings - Fiscal Standard
06/10/16 04:20 PMEndoChoice Holdings, Inc. (NYSE:GI) Current Analyst Ratings - Fiscal Standard
06/08/16 04:27 PMENDOCHOICE HOLDINGS INC. (NYSE:GI) Financial Condition Compared to S&P 500 - CML News
06/06/16 04:04 PMEndoChoice Holdings, Inc. (NYSE:GI) Plummeted -9.14%: Nortel Inversora S.A. (NYSE:NTL), Radian Group Inc. (NYSE ... - KC Register
06/02/16 04:49 AMStock Review and Earnings Check on EndoChoice Holdings Inc (NYSE:GI) - HNN - Stock Review and Earnings Check on EndoChoice Holdings Inc (NYSE:GI)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting EndoChoice Holdings Inc ...and more »
06/02/16 04:49 AMEndoChoice Holdings, Inc. (NYSE:GI) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - EndoChoice Holdings, Inc. (NYSE:GI) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of EndoChoice Holdings, Inc. (NYSE:GI). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts ...
06/01/16 08:23 AMEndoChoice® to Present at William Blair & Company's 36th Annual Growth Stock Conference - [at noodls] - 5fec3cdd-6832-4013-83a5-3d6afeb60e77.pdf EndoChoice® to Present at William Blair & Company's 36th Annual Growth Stock Conference Jun 01, 2016 ALPHARETTA, Ga., June 1, 2016 /PRNewswire/ -- EndoChoice Holdings, ...
05/31/16 04:23 PMThe Growth Forecast For EndoChoice Holdings Inc (NYSE:GI) - RealistInvestor.com - The Growth Forecast For EndoChoice Holdings Inc (NYSE:GI)RealistInvestor.comWall Street renowned brokerages following EndoChoice Holdings Inc (NYSE:GI) have now given a mean price target of $10 on its stock. After accomplishing a methodical study, the analysts have specified a target price range. The intense high range is put ...and more »
05/28/16 09:35 AMEndoChoice launches third generation Fuse Full Spectrum Endoscopy system - ALPHARETTA, Ga., May 19, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today the full market release of its Generation 3 Full Spectrum Endoscopy® (Fuse®) system. Fuse Generation 3 includes an ergonomically advanced control body ...
05/26/16 04:53 PMEarnings Review and Stock Rundown for EndoChoice Holdings Inc (NYSE:GI) - Wall Street Hints and News - Earnings Review and Stock Rundown for EndoChoice Holdings Inc (NYSE:GI)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting EndoChoice Holdings Inc (NYSE:GI) to post ...and more »
05/26/16 11:53 AMStock Rating Review for EndoChoice Holdings Inc (NYSE:GI) - Wall Street Hints and News - Stock Rating Review for EndoChoice Holdings Inc (NYSE:GI)Wall Street Hints and NewsInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.75 on shares of EndoChoice Holdings Inc (NYSE:GI). Covering analysts ...
05/25/16 01:59 PMEndochoice Holdings Incorporated (NYSE:GI) Shorts Decreased by 0.79% After Short Covering - Wall Street Hints and News - Endochoice Holdings Incorporated (NYSE:GI) Shorts Decreased by 0.79% After Short CoveringWall Street Hints and NewsThe short interest to Endochoice Holdings Incorporated's float is 9.17%. The stock is up 0.46% or $0.02 after the news, hitting $4.37 per share. About 83,920 shares traded hands or 62.93% up from the average. EndoChoice Holdings Inc (NYSE:GI) has ...and more »
05/23/16 12:06 PMEndoChoice® Announces FDA Clearance of its Orca™ Sterile, Single-Use Air/Water and Suction Valves - [at noodls] - b8d615c0-00dd-4508-b51c-7e7077357987.pdf May 23, 2016 ALPHARETTA, Ga., May 23, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced it received 510(k) clearance for its new Orca™ sterile, ...
05/22/16 01:58 PMEndoChoice Holdings Inc (NYSE:GI) One-Year Price Projection At $10 - Stocks Daily - EndoChoice Holdings Inc (NYSE:GI) One-Year Price Projection At $10Stocks DailySell-side analysts are certain on the prospect of EndoChoice Holdings Inc (NYSE:GI) stock. As of 2016-05-20, the stock ABR stands at 1.75. This type of rating states that whenever a stock has a score of 5, investors should avoid investing in such stocks.and more »
05/22/16 01:58 PMNext Weeks Broker Price Targets For EndoChoice Holdings, Inc. (NYSE:GI) - Share Trading News - Next Weeks Broker Price Targets For EndoChoice Holdings, Inc. (NYSE:GI)Share Trading NewsEndoChoice Holdings, Inc. has a 50 day moving average of 5.07 and a 200 day moving average of 6.34. The stock's market capitalization is 117.31M, it has a 52-week low of 3.70 and a 52-week high of 19.69. The share price of the company (NYSE:GI) was ...
05/19/16 05:52 PMEndoChoice® Launches Third Generation Fuse® Full Spectrum Endoscopy® System - [at noodls] - 5c1d2595-7f49-42a7-9a5b-e421cac057a2.pdf May 19, 2016 ALPHARETTA, Ga., May 19, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today the full market release of its Generation 3 Full ...
05/19/16 10:32 AMEndoChoice® Launches RescueNet™ Retrieval Device - [at noodls] - 14b5d613-2196-4293-970d-a87f2cce8bf1.pdf May 19, 2016 ALPHARETTA, Ga., May 19, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced the full market release of its RescueNet™ retrieval device. ...
05/12/16 01:31 PMConsensus Rating Review for EndoChoice Holdings Inc (NYSE:GI) - B.O.D.Y Confidential - Consensus Rating Review for EndoChoice Holdings Inc (NYSE:GI)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1.75 on shares of EndoChoice Holdings Inc (NYSE:GI). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy, Sell ...and more »
05/11/16 10:45 AMEndoChoice Holdings, Inc. :GI-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 12:04 PMENDOCHOICE HOLDINGS, INC. Financials -
05/08/16 12:52 PMAfter Last Week What Do Analysts Think Of EndoChoice Holdings, Inc. (NYSE:GI) - Share Trading News - After Last Week What Do Analysts Think Of EndoChoice Holdings, Inc. (NYSE:GI)Share Trading NewsThe share price of EndoChoice Holdings, Inc. (NYSE:GI) was up +4.55% during the last trading session, with a day high of 5.12. 47882 shares were traded on EndoChoice Holdings, Inc.'s last session. The stock's 50 day moving average is 5.22 and its 200 ...EndoChoice Holdings' (GI) CEO Mark Gilreath on Q1 2016 Results - Earnings Call TranscriptSeeking Alphaall 2 news articles »
05/07/16 01:07 PMEarnings Outlook on EndoChoice Holdings Inc (NYSE:GI) - B.O.D.Y Confidential - Earnings Outlook on EndoChoice Holdings Inc (NYSE:GI)B.O.D.Y ConfidentialAnalysts and investors will be anticipating EndoChoice Holdings Inc (NYSE:GI)'s next earnings release which is expected to be posted on or around 2016-05-04. Sell-side research firms on Wall Street are expecting that the company will post EPS of $-0.54 ...and more »
05/07/16 01:07 PMBroker Roundup For EndoChoice Holdings, Inc. (NYSE:GI) - Share Trading News - Broker Roundup For EndoChoice Holdings, Inc. (NYSE:GI)Share Trading NewsThe share price of EndoChoice Holdings, Inc. (NYSE:GI) was down -5.49% during the last trading session, with a day high of 5.41. 69564 shares were traded on EndoChoice Holdings, Inc.'s last session. The stock's 50 day moving average is 5.26 and its 200 ...
05/07/16 01:07 PMEndoChoice Holdings Inc (NYSE:GI) ABR Of 1.75 - Stocks Daily - EndoChoice Holdings Inc (NYSE:GI) ABR Of 1.75Stocks DailyThere are numerous brokerages operating in the market, and each one of them uses a different process to prepare the research reports on a stock. As a result, investors have to study more than one research report before taking an investment call on a stock.and more »
05/04/16 04:34 PMENDOCHOICE HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V -
05/04/16 01:09 PMAverage Analyst Rating for EndoChoice Holdings Inc (NYSE:GI) - B.O.D.Y Confidential - Average Analyst Rating for EndoChoice Holdings Inc (NYSE:GI)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1.75 on EndoChoice Holdings Inc (NYSE:GI) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/04/16 06:30 AMNew Clinical Evidence to be Presented on the Fuse® Full Spectrum Endoscopy® system at DDW® 2016 - [at noodls] - 1ff22497-3cbc-4062-bfe9-543389d9d907.pdf May 04, 2016 ALPHARETTA, Ga., May 4, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced that the Company will participate at the Digestive Disease ...
05/04/16 06:30 AMEndoChoice Announces First Quarter 2016 Financial Results - [at noodls] - 75395683-69fe-4004-b155-a28a9c8035b1.pdf May 04, 2016 ALPHARETTA, Ga., May 4, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today financial results for the first quarter 2016. ... ...
05/04/16 06:24 AMENDOCHOICE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report -
05/04/16 06:12 AMEndoChoice reports 1Q loss -
05/04/16 06:07 AMQ1 2016 EndoChoice Holdings Inc Earnings Release - Before Market Open -
05/03/16 01:25 PMEndoChoice Holdings Inc.: EndoChoice® Announces William Enquist as New Chairman of the Board - The Wall Street Transcript - EndoChoice Holdings Inc.: EndoChoice® Announces William Enquist as New Chairman of the BoardThe Wall Street TranscriptALPHARETTA, Ga., May 2, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today that existing Board member William (Bill) Enquist has been elevated to the position of Chairman of the Board of Directors. Scott Huennekens, who has ...and more »
05/03/16 09:10 AMEndoChoice® to Present at Investor Conferences in May 2016 - [at noodls] - fa534324-7c03-4a78-8880-811dde2fcd28.pdf May 03, 2016 ALPHARETTA, Ga., May 3, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today that Mark Gilreath, Founder and CEO, and David Gill, ...
05/02/16 07:30 AMEndoChoice® Announces William Enquist as New Chairman of the Board - [at noodls] - 0d60d7d9-13ab-4695-92be-6ceb8f028d4c.pdf May 02, 2016 ALPHARETTA, Ga., May 2, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today that existing Board member William (Bill) Enquist ...
05/02/16 07:04 AM8:04 am EndoChoice announces William (Bill) Enquist as Chairman of the Board -
05/01/16 01:17 PMEndochoice Holdings Incorporated (NYSE:GI) Short Interest Increased By 9.8% - B.O.D.Y Confidential - Endochoice Holdings Incorporated (NYSE:GI) Short Interest Increased By 9.8%B.O.D.Y ConfidentialThe short interest to Endochoice Holdings Incorporated's float is 9.25%. The stock increased 1.85% or $0.1 on April 29, hitting $5.52. EndoChoice Holdings Inc (NYSE:GI) has declined 57.93% since September 24, 2015 and is downtrending.and more »
04/30/16 01:37 PMShare Performance and Target Price Review EndoChoice Holdings Inc (NYSE:GI) - B.O.D.Y Confidential - Share Performance and Target Price Review EndoChoice Holdings Inc (NYSE:GI)B.O.D.Y ConfidentialDuring the most recent trading session, shares of EndoChoice Holdings Inc (NYSE:GI) ended up with a move of +0.18%. Sell-side analysts have given a consensus target price of $10.00 on company shares. Target price projections may differ greatly from one ...and more »
04/29/16 01:34 PMTracking Earnings for EndoChoice Holdings Inc (NYSE:GI) - B.O.D.Y Confidential - Tracking Earnings for EndoChoice Holdings Inc (NYSE:GI)B.O.D.Y ConfidentialEndoChoice Holdings Inc (NYSE:GI) has a current consensus EPS estimate for the quarter of $-0.54 based on Street analyst predictions. The company is scheduled to next report earnings information on or around 2016-05-04 for the period ending ...and more »
04/27/16 01:54 PMEndoChoice Holdings, Inc. (NYSE:GI) Updated Analyst Coverage - Risers & Fallers - EndoChoice Holdings, Inc. (NYSE:GI) Updated Analyst CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of EndoChoice Holdings, Inc. (NYSE:GI). According to the latest broker reports outstanding on Monday 25th of April, 0 analysts have a rating of “strong buy”, 0 analysts ...EndoChoice Holdings, Inc. (NYSE:GI) Broker Price Targets For The Coming WeekShare Trading Newsall 2 news articles »
04/27/16 01:54 PMEndoChoice Holdings Inc (NYSE:GI) Share Rating Recap - The Post - EndoChoice Holdings Inc (NYSE:GI) Share Rating RecapThe PostShares of EndoChoice Holdings Inc (NYSE:GI) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/22/16 01:56 PMCurrent Price Targets For EndoChoice Holdings, Inc. (NYSE:GI) - Risers & Fallers - Current Price Targets For EndoChoice Holdings, Inc. (NYSE:GI)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of EndoChoice Holdings, Inc. (NYSE:GI). The latest broker reports which are currently outstanding on Friday 22nd of April state 0 analysts have a rating of “strong buy”, 0 ...
03/10/16 12:51 PMETF’s with exposure to EndoChoice Holdings, Inc. : March 10, 2016 -
03/09/16 10:52 AMEndoChoice Holdings, Inc. :GI-US: Earnings Analysis: 2015 By the Numbers -
03/03/16 06:30 AMEndoChoice reports 4Q loss -
03/03/16 06:19 AMENDOCHOICE HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or P -
About EndoChoice Holdings

EndoChoice Holdings logoEndochoice Holdings, Inc., formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems. The Company's Fuse system, an endoscopy system used for visualization of the GI tract and related therapeutic interventions, enables a wider field of view for upper and lower endoscopy procedures. The Fuse colonoscope offers a 330° view of the colon during colonoscopy instead of the 140° to 170° view offered by standard colonoscopes. Its CinchPad is used to improve the transport process of endoscopes after use. The Company's products are used in colonoscopy and esophagogastroduodenoscopy (EGD) and other procedures of the upper GI tract. The Company serves over 2,500 GI departments that perform endoscopic procedures.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: GI
  • CUSIP:
Key Metrics:
  • Previous Close: $4.82
  • 50 Day Moving Average: $4.48
  • 200 Day Moving Average: $5.55
  • P/E Ratio: N/A
  • P/E Growth: -0.12
  • Market Cap: $125.37M
  • Current Quarter EPS Consensus Estimate: $-2.01 EPS
Additional Links:
EndoChoice Holdings (NYSE:GI) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha